These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26380822)

  • 1. Vitamin K and hepatocellular carcinoma: The basic and clinic.
    Jinghe X; Mizuta T; Ozaki I
    World J Clin Cases; 2015 Sep; 3(9):757-64. PubMed ID: 26380822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatocellular carcinoma and vitamin K2].
    Mizuta T; Ozaki I
    Clin Calcium; 2015 Nov; 25(11):1645-51. PubMed ID: 26503869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of vitamin K for hepatocellular carcinoma].
    Mizuta T; Ozaki I
    Clin Calcium; 2007 Nov; 17(11):1693-9. PubMed ID: 17982189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma.
    Yoshiji H; Noguchi R; Toyohara M; Ikenaka Y; Kitade M; Kaji K; Yamazaki M; Yamao J; Mitoro A; Sawai M; Yoshida M; Fujimoto M; Tsujimoto T; Kawaratani H; Uemura M; Fukui H
    J Hepatol; 2009 Aug; 51(2):315-21. PubMed ID: 19501932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cells.
    Kanamori T; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Tsurumi H; Kojima S; Moriwaki H
    Cancer Sci; 2007 Mar; 98(3):431-7. PubMed ID: 17270033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
    Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Akahane T; Asada K; Tsujimoto T; Uemura M; Fukui H
    Oncol Rep; 2006 Jan; 15(1):155-9. PubMed ID: 16328049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression.
    Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Masaki T; Fukui H
    J Hepatol; 2005 May; 42(5):687-93. PubMed ID: 15826718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo.
    Wei G; Wang M; Hyslop T; Wang Z; Carr BI
    Int J Cancer; 2010 Dec; 127(12):2949-58. PubMed ID: 21351273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents.
    Yoshiji H; Noguchi R; Ikenaka Y; Kaji K; Shirai Y; Aihara Y; Yamao J; Toyohara M; Mitoro A; Sawai M; Yoshida M; Morioka C; Fujimoto M; Uemura M; Kawaratani H; Tsujimoto T; Fukui H
    Oncol Lett; 2011 Jan; 2(1):69-73. PubMed ID: 22870131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative use of the chemopreventive vitamin K2 analog in patients with hepatocellular carcinoma.
    Zhong JH; Mo XS; Xiang BD; Yuan WP; Jiang JF; Xie GS; Li LQ
    PLoS One; 2013; 8(3):e58082. PubMed ID: 23505456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin K2 on the recurrence in patients with hepatocellular carcinoma.
    Hotta N; Ayada M; Sato K; Ishikawa T; Okumura A; Matsumoto E; Ohashi T; Kakumu S
    Hepatogastroenterology; 2007; 54(79):2073-7. PubMed ID: 18251162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxylic Derivatives of Vitamin K2 Inhibit Hepatocellular Carcinoma Cell Growth through Caspase/Transglutaminase-Related Signaling Pathways.
    Qin XY; Fujii S; Shimizu A; Kagechika H; Kojima S
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(4):285-90. PubMed ID: 26440634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naturally occurring K vitamins inhibit pancreatic cancer cell survival through a caspase-dependent pathway.
    Showalter SL; Wang Z; Costantino CL; Witkiewicz AK; Yeo CJ; Brody JR; Carr BI
    J Gastroenterol Hepatol; 2010 Apr; 25(4):738-44. PubMed ID: 19929921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential of Vitamin K as a Regulatory Factor of Bone Metabolism-A Review.
    Wang H; Ma Y
    Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin analogues in chemoprevention of hepatocellular carcinoma after resection or ablation--a systematic review and meta-analysis.
    Chu KJ; Lai EC; Yao XP; Zhang HW; Lau WY; Fu XH; Lu CD; Shi J; Cheng SQ
    Asian J Surg; 2010 Jul; 33(3):120-6. PubMed ID: 21163409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials.
    Riaz IB; Riaz H; Riaz T; Rahman S; Amir M; Badshah MB; Kazi AN
    BMC Gastroenterol; 2012 Nov; 12():170. PubMed ID: 23191943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of renin-angiotensin system in hepatocellular carcinoma.
    Yoshiji H; Noguchi R; Ikenaka Y; Kaji K; Aihara Y; Fukui H
    Curr Cancer Drug Targets; 2011 May; 11(4):431-41. PubMed ID: 21395547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma.
    Barone M; Viggiani MT; Losurdo G; Principi M; Leo AD
    World J Gastroenterol; 2019 May; 25(20):2524-2538. PubMed ID: 31171895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete response by vitamin K2 analog monotherapy in sorafenib-failure advanced hepatocellular carcinoma: A case report.
    Kuzuya T; Ishigami M; Ishizu Y; Honda T; Hayashi K; Ishikawa T; Hirooka Y; Goto H
    Hepatol Res; 2019 Mar; 49(3):360-364. PubMed ID: 30051950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.